{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T06:55:54Z","timestamp":1774076154918,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005190","name":"Melanoma Research Alliance","doi-asserted-by":"publisher","award":["615,808"],"award-info":[{"award-number":["615,808"]}],"id":[{"id":"10.13039\/100005190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001698","name":"Israel Cancer Research Fund","doi-asserted-by":"publisher","award":["PROF-18-682"],"award-info":[{"award-number":["PROF-18-682"]}],"id":[{"id":"10.13039\/100001698","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006111","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior","doi-asserted-by":"publisher","award":["2023.08262"],"award-info":[{"award-number":["2023.08262"]}],"id":[{"id":"10.13039\/501100006111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"Caixabank SA","doi-asserted-by":"publisher","award":["LCF\/TR\/CD20\/52700005"],"award-info":[{"award-number":["LCF\/TR\/CD20\/52700005"]}],"id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"Caixabank SA","doi-asserted-by":"publisher","award":["LCF\/PR\/HR24\/00968"],"award-info":[{"award-number":["LCF\/PR\/HR24\/00968"]}],"id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"Caixabank SA","doi-asserted-by":"publisher","award":["LCF\/PR\/ HR21 \/52410028"],"award-info":[{"award-number":["LCF\/PR\/ HR21 \/52410028"]}],"id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"Caixabank SA","doi-asserted-by":"publisher","award":["LCF\/PR\/HR19\/52160021"],"award-info":[{"award-number":["LCF\/PR\/HR19\/52160021"]}],"id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"Caixabank SA","doi-asserted-by":"publisher","award":["LCF\/PR\/HR22\/52420016"],"award-info":[{"award-number":["LCF\/PR\/HR22\/52420016"]}],"id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["3706\/24"],"award-info":[{"award-number":["3706\/24"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["SFRH\/BD\/131969\/2017"],"award-info":[{"award-number":["SFRH\/BD\/131969\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["UTAP-EXPL\/NPN\/0041\/2021"],"award-info":[{"award-number":["UTAP-EXPL\/NPN\/0041\/2021"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["PTDC\/BTM-SAL\/4350\/2021"],"award-info":[{"award-number":["PTDC\/BTM-SAL\/4350\/2021"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019180","name":"HORIZON EUROPE European Research Council","doi-asserted-by":"publisher","award":["835227"],"award-info":[{"award-number":["835227"]}],"id":[{"id":"10.13039\/100019180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019180","name":"HORIZON EUROPE European Research Council","doi-asserted-by":"publisher","award":["101113390"],"award-info":[{"award-number":["101113390"]}],"id":[{"id":"10.13039\/100019180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019180","name":"HORIZON EUROPE European Research Council","doi-asserted-by":"publisher","award":["862580 \\u20133DCanPredict"],"award-info":[{"award-number":["862580 \\u20133DCanPredict"]}],"id":[{"id":"10.13039\/100019180","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jconrel.2025.114178","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T23:13:48Z","timestamp":1756509228000},"page":"114178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Polymeric-based neoantigen nanovaccine synergizes with PD-1\/PD-L1 modulators, reprogramming the melanoma microenvironment"],"prefix":"10.1016","volume":"387","author":[{"given":"B\u00e1rbara","family":"Carreira","sequence":"first","affiliation":[]},{"given":"Rita C.","family":"Ac\u00farcio","sequence":"additional","affiliation":[]},{"given":"Ana I.","family":"Matos","sequence":"additional","affiliation":[]},{"given":"Liane I.F.","family":"Moura","sequence":"additional","affiliation":[]},{"given":"Marta B.","family":"Afonso","sequence":"additional","affiliation":[]},{"given":"Ana S.","family":"Viana","sequence":"additional","affiliation":[]},{"given":"F\u00e1bio M.F.","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Pedro M.P.","family":"Gois","sequence":"additional","affiliation":[]},{"given":"Cec\u00edlia M.P.","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Rita C.","family":"Guedes","sequence":"additional","affiliation":[]},{"given":"Ronit","family":"Satchi-Fainaro","sequence":"additional","affiliation":[]},{"given":"Helena F.","family":"Florindo","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114178_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114295","article-title":"Early versus late response to PD-1-based immunotherapy in metastatic melanoma","volume":"210","author":"Lodde","year":"2024","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jconrel.2025.114178_bb0010","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/d41573-020-00204-y","article-title":"Combinations take Centre stage in PD1\/PDL1 inhibitor clinical trials","volume":"20","author":"Upadhaya","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.114178_bb0015","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1200\/JCO.2017.77.6385","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American society of clinical oncology clinical practice guideline","volume":"36","author":"Brahmer","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.114178_bb0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejca.2015.11.016","article-title":"Immune-related adverse events with immune checkpoint blockade: a comprehensive review","volume":"54","author":"Michot","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jconrel.2025.114178_bb0025","first-page":"83","article-title":"Monoclonal antibodies for the treatment of melanoma: present and future strategies","volume":"2019","author":"Bhandaru","year":"1904","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2025.114178_bb0030","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.ccell.2022.08.003","article-title":"Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer","volume":"40","author":"Awad","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2025.114178_bb0035","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cell.2020.08.053","article-title":"A phase Ib trial of personalized Neoantigen therapy plus anti-PD-1 in patients with advanced melanoma, non-small cell lung cancer, or bladder cancer","volume":"183","author":"Ott","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2025.114178_bb0040","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1016\/j.cell.2021.08.020","article-title":"Antigen dominance hierarchies shape TCF1+ progenitor CD8 T cell phenotypes in tumors","volume":"184","author":"Burger","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2025.114178_bb0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-021-03704-y","article-title":"Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma","volume":"596","author":"Oliveira","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114178_bb0050","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2210385120","article-title":"Photoactivatable nanoagonists chemically programmed for pharmacokinetic tuning and in situ cancer vaccination","volume":"120","author":"Wan","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.114178_bb0055","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/s41565-019-0512-0","article-title":"Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators","volume":"14","author":"Conniot","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.114178_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202401749","article-title":"Multifunctional Nanovaccine sensitizes breast Cancer to immune checkpoint therapy","volume":"34","author":"Peres","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2025.114178_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202300299","article-title":"Polyoxazoline-based Nanovaccine synergizes with tumor-associated macrophage targeting and anti-PD-1 immunotherapy against solid tumors","volume":"10","author":"Matos","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.114178_bb0070","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.canlet.2018.11.039","article-title":"Immune checkpoint ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes","volume":"444","author":"Sun","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2025.114178_bb0075","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1172\/JCI96061","article-title":"PD-L1 on host cells is essential for PD-L1 blockade\u2013mediated tumor regression","volume":"128","author":"Tang","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2025.114178_bb0080","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav7431","article-title":"Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy","volume":"12","author":"Mayoux","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114178_bb0085","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1158\/0008-5472.CAN-11-3722","article-title":"Exploiting the mutanome for tumor vaccination","volume":"72","author":"Castle","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114178_bb0090","doi-asserted-by":"crossref","first-page":"1383456","DOI":"10.3389\/fimmu.2024.1383456","article-title":"Targeting PD-1\/PD-L-1 immune checkpoint inhibition for cancer immunotherapy: success and challenges","volume":"15","author":"Javed","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114178_bb0095","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004695","article-title":"Therapeutic targeting of PD-1\/PD-L1 blockade by novel small-molecule inhibitors recruits cytotoxic T cells into solid tumor microenvironment","volume":"10","author":"Ac\u00farcio","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2025.114178_bb0100","first-page":"1","article-title":"Small molecule inhibitors against PD-1\/PD-L1 immune checkpoints and current methodologies for their development: a review","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.jconrel.2025.114178_bb0105","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.drudis.2016.04.011","article-title":"From monoclonal antibodies to small molecules: the development of inhibitors targeting the PD-1\/PD-L1 pathway","volume":"21","author":"Zhan","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2025.114178_bb0110","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1016\/j.biomaterials.2009.05.045","article-title":"Antibody and cytokine-associated immune responses to S. Equi antigens entrapped in PLA nanospheres","volume":"30","author":"Florindo","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114178_bb0115","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.176.6.1693","article-title":"Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte\/macrophage colony-stimulating factor","volume":"176","author":"Inaba","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2025.114178_bb0120","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114178_bb0125","first-page":"1297","article-title":"Neoantigen: a new breakthrough in tumor immunotherapy","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114178_bb0130","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1084\/jem.20041964","article-title":"A type I interferon autocrine-paracrine loop is involved in toll-like receptor-induced interleukin-12p70 secretion by dendritic cells","volume":"201","author":"Gautier","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2025.114178_bb0135","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.coi.2009.12.005","article-title":"TLR signalling regulated antigen presentation in dendritic cells","volume":"22","author":"Watts","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2025.114178_bb0140","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/21645515.2017.1420446","article-title":"Synergy effects of Polyinosinic-polycytidylic acid, CpG oligodeoxynucleotide, and cationic peptides to adjuvant HPV E7 epitope vaccine through preventive and therapeutic immunization in a TC-1 grafted mouse model","volume":"14","author":"Liu","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jconrel.2025.114178_bb0145","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jconrel.2017.01.004","article-title":"Encapsulation of two different TLR ligands into liposomes confer protective immunity and prevent tumor development","volume":"247","author":"Bayyurt","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114178_bb0150","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1021\/bm401141u","article-title":"Development of PLGA-mannosamine nanoparticles as oral protein carriers","volume":"14","author":"Alonso-Sande","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2025.114178_bb0155","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/mabi.200700022","article-title":"PLA nano- and microparticles for drug delivery: an overview of the methods of preparation","volume":"7","author":"Lassalle","year":"2007","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2025.114178_bb0160","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.biotechadv.2011.06.019","article-title":"Poly-lactic acid synthesis for application in biomedical devices - a review","volume":"30","author":"Lasprilla","year":"2012","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jconrel.2025.114178_bb0165","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40005-019-00439-x","article-title":"Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)\/poly(lactic-co-glycolic acid) micro and nanoparticles","volume":"49","author":"Elmowafy","year":"2019","journal-title":"J. Pharm. Invest."},{"key":"10.1016\/j.jconrel.2025.114178_bb0170","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1016\/j.biomaterials.2008.02.020","article-title":"Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles","volume":"29","author":"Pan","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114178_bb0175","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.celrep.2016.04.007","article-title":"Targeted delivery of immunomodulators to lymph nodes","volume":"15","author":"Azzi","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2025.114178_bb0180","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1016\/j.biomaterials.2012.03.041","article-title":"Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype","volume":"33","author":"Demento","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114178_bb0185","series-title":"Biochem Soc Trans, Biochem Soc Trans","first-page":"1478","article-title":"C-type lectins on dendritic cells: Key modulators for the induction of immune responses","author":"van Kooyk","year":"2008"},{"key":"10.1016\/j.jconrel.2025.114178_bb0190","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.coi.2006.03.017","article-title":"Expanding the effector CD4 T-cell repertoire: the Th17 lineage","volume":"18","author":"Harrington","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2025.114178_bb0195","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ni928","article-title":"Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes","volume":"4","author":"Bousso","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2025.114178_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019346","article-title":"Distribution of primed T cells and antigen-loaded antigen presenting cells following intranasal immunization in mice","volume":"6","author":"Ciabattini","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2025.114178_bb0205","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.4049\/jimmunol.0804344","article-title":"TLR-induced local metabolism of vitamin D3 plays an important role in the diversification of adaptive immune responses","volume":"182","author":"Enioutina","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.114178_bb0210","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2025.114178_bb0215","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0952-7915(00)00211-9","article-title":"Generation and maintenance of memory T cells","volume":"13","author":"Sprent","year":"2001","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2025.114178_bb0220","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1002\/eji.200535184","article-title":"Vaccine route, dose and type of delivery vector determine patterns of primary CD8+ T cell responses","volume":"35","author":"Estcourt","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2025.114178_bb0225","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/sj.cgt.7700653","article-title":"Vaccine-induced CD8+ T cells eliminate tumors by a two-staged attack","volume":"10","author":"Kowalczyk","year":"2003","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.jconrel.2025.114178_bb0230","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41577-018-0046-y","article-title":"Biology and regulation of IL-2: from molecular mechanisms to human therapy","volume":"18","author":"Spolski","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114178_bb0235","first-page":"13","article-title":"Interleukin-2 at the crossroads of effector responses","volume":"38","author":"Liao","year":"2013","journal-title":"Tolerance, Immunother. Immunity"},{"key":"10.1016\/j.jconrel.2025.114178_bb0240","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ni969","article-title":"Similarities and differences in CD4+ and CD8+ effector and memory T cell generation","volume":"4","author":"Seder","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2025.114178_bb0245","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114178_bb0250","doi-asserted-by":"crossref","first-page":"200ra116","DOI":"10.1126\/scitranslmed.3006504","article-title":"Up-regulation of PD-L1, IDO, and Tregs in the melanoma tumor microenvironment is driven by CD8+ T cells","volume":"5","author":"Spranger","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114178_bb0255","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.canlet.2017.07.029","article-title":"PD-1\/PD-L1 blockade enhances the efficacy of SA-GM-CSF surface-modified tumor vaccine in prostate cancer","volume":"406","author":"Shi","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2025.114178_bb0260","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd2712","article-title":"Revisiting the PD-1 pathway","volume":"6","author":"Patsoukis","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2025.114178_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-33720-z","article-title":"Evolution and modulation of antigen-specific T cell responses in melanoma patients","volume":"13","author":"Huuhtanen","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114178_bb0270","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.1158\/1078-0432.CCR-15-0676","article-title":"Myeloid cells and related chronic inflammatory factors as novel predictive markers in melanoma treatment with ipilimumab","volume":"21","author":"Gebhardt","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114178_bb0275","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1158\/2326-6066.CIR-15-0193","article-title":"Phase I\/II study of metastatic melanoma patients treated with nivolumab who had progressed after ipilimumab","volume":"4","author":"Weber","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jconrel.2025.114178_bb0280","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.1158\/1078-0432.CCR-15-3104","article-title":"Clinical significance of circulating CD33+ CD11bHLA-DR myeloid cells in patients with stage IV melanoma treated with ipilimumab","volume":"22","author":"Sade-Feldman","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114178_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-18570-x","article-title":"PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade","volume":"11","author":"Peng","year":"2020","journal-title":"Nat. Commun."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925007904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925007904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T03:40:12Z","timestamp":1774064412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925007904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":57,"alternative-id":["S0168365925007904"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114178","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymeric-based neoantigen nanovaccine synergizes with PD-1\/PD-L1 modulators, reprogramming the melanoma microenvironment","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114178","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114178"}}